Insights On Clinical Technologies
-
Biotech Landscape Continues To Shift
9/18/2025
Global shifts are adding new layers of challenge and opportunity for the biotech sector, as companies navigate a period of unprecedented complexity.
-
How eCOA Improves Data Quality In Clinical Trials
11/20/2024
eCOA solutions enhance data quality in clinical trials by preventing common issues in paper-based COA data, such as missing, ambiguous, or conflicting entries, and ensuring reliable data collection.
-
Castor eConsent: Site View
8/21/2025
Study coordinators aim to enroll participants efficiently through a partnership that leverages direct-to-patient marketing to streamline recruitment.
-
The AI Revolution In Clinical Trials
11/13/2025
AI is reshaping clinical trials by accelerating patient recruitment, optimizing protocol design, and improving data quality—driving faster, more efficient, and more inclusive research outcomes.
-
Strategies For A More Secure Outsourcing Bottom Line
7/9/2024
A panel of experts from across the pharmaceutical/biopharmaceutical industry recently shared their experiences in mitigating financial risk before partnering with a contract research organization (CRO).
-
How Viracta Therapeutics Transformed Operations With NetSuite
10/8/2024
Explore how a virtual biotech company overcame their challenges with QuickBooks software by embracing a new system with automated processes.
-
Do CROs Need To Reinvent Themselves In 2025?
3/21/2025
Facing economic pressures, regulatory changes, and technological advancements, CROs must redefine their value propositions and discuss the need for reinvention in 2025 to accelerate into the future.
-
eCOA Licensing Guide
3/7/2024
In this comprehensive guide, IQVIA's eCOA library and licensing specialists, Kayla Doyle and Piero Bindi, explore five essential steps for obtaining licenses for the assessments required in your clinical trial.
-
A Day In The Life Of A Clinical Research Site
4/22/2025
Clinical research site coordinators are the unsung heroes of trial execution—managing complex protocols, supporting participants, and navigating fragmented systems, all while ensuring study integrity.
-
Letter From The CEO: A New Era Of Drug Development Is Here
9/3/2024
This letter from Medable CEO Michelle Longmire lays out why we created Studio, what it enables sponsors and CROs to do, and how it will help everyone bring more effective therapies to patients faster.